David Marcus Wang MD MPH, FAAD (He/Him)
Dermatologic Surgery
Mohs Surgeon and Dermatologist
Join to View Full Profile
7575 San Felipe St#300Houston, TX 77063
Phone+1 713-952-8400
Dr. Wang is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Double board-certified Mohs surgeon and dermatologist
Education & Training
Mass General Brigham/Brigham and Women's HospitalFellowship, Micrographic Surgery and Dermatologic Oncology, 2022 - 2024
Harvard School of Public HealthMaster of Public Health (M.P.H.), Clinical Effectiveness track, 2022 - 2024
University of North Carolina HospitalsChief Residency, Dermatology, 2021 - 2022- University of North Carolina HospitalsResidency, Dermatology, 2019 - 2022
The MetroHealth SystemInternship, Preliminary Year, 2018 - 2019
Case Western Reserve University School of MedicineClass of 2018, Doctor of Medicine (M.D.), Alpha Omega Alpha- Harvard UniversityAB, Economics, 2008 - 2012
Certifications & Licensure
TX State Medical License 2024 - 2026
MA State Medical License 2022 - 2025
NC State Medical License 2019 - 2023
OH State Medical License 2018 - 2021
American Board of Dermatology Dermatology
Awards, Honors, & Recognition
- Theodore Tromovitch Award American College of Mohs Surgery, 2024
- Alpha Omega Alpha 2018
Publications & Presentations
PubMed
- Assessing outcomes of cutaneous squamous cell carcinoma with large-calibre nerve invasion as solitary high-risk factor: A single-institution cohort study.Nicole Loranger, Emily Karn, David Wang, Chrysalyne Schmults, Emily Ruiz
Journal of the European Academy of Dermatology and Venereology. 2025-04-01 - CLO25-055: Metastasis-Free Survival Prediction With the 40-Gene Expression Profile Test in Patients With Cutaneous Squamous Cell Carcinoma Risk Stratified According to...Emily S Ruiz, Karina Brito, Emily E Karn, R'ay Fodor, Allison T Vidimos
Journal of the National Comprehensive Cancer Network. 2025-03-28 - riSCC: A personalized risk model for the development of poor outcomes in cutaneous squamous cell carcinoma.Anokhi Jambusaria-Pahlajani, Vincent Jeanselme, David M Wang, Nina A Ran, Emily E Granger
Journal of the American Academy of Dermatology. 2025-02-28
Press Mentions
Mohs Surgery Shows Superior Outcomes in Squamous Cell Skin CancerFebruary 19th, 2025
Professional Memberships
- Member
- Member
- Member
- American College of Mohs Surgery - ACMSMember
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
